{"id":737556,"title":"National safety monitoring of vaccines from CAEFISS, 2018-2019 - Canada.ca","sourceCode":"phac","sourceName":"Public Health Agency of Canada","language":"en","captureDate":"2026-02-16","captureTimestamp":"2026-02-16T06:10:14.228000+00:00","jobId":7,"originalUrl":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2024-50/issue-1-2-january-february-2024/national-safety-monitoring-vaccines-caefiss-2018-2019.html","snippet":"National safety monitoring of vaccines from CAEFISS, 2018-2019 Download this article as a PDF (404 KB) Published by: The Public Health Agency of Canada Issue: Volume 50-1/2, January/February 2024: Respiratory Syncytial Virus (RSV) Date published: January/February 2024 ISSN:…","rawSnapshotUrl":"/api/snapshots/raw/737556","browseUrl":"https://replay.healtharchive.ca/job-7/20260216061014/https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2024-50/issue-1-2-january-february-2024/national-safety-monitoring-vaccines-caefiss-2018-2019.html#ha_snapshot=737556","mimeType":"text/html","statusCode":200,"captureBackend":"playwright_warc","captureFidelity":"fallback"}